Abstract
GV1001, a synthetic peptide derived from human telomerase, has a range of diverse biological activities, including an antioxidant function. Here, we investigated the role of GV1001 in hepatitis C virus (HCV)-infected Huh7.5 (JFH-1) cells. We showed that GV1001 inhibited the production of ROS with decreased MAP kinase signaling. Interestingly, GV1001 lost its antioxidant activity as ROS levels decreased, resulting in a reduction in extracellular heat shock protein 90 (eHSP90) as low-density lipoprotein receptor-related protein 1 (LRP1) was blocked or knocked-down. GV1001 binds to eHSP90 and is delivered into the cell by endocytosis via LRP1. Endocytosed GV1001 finally suppressed ROS generation, presumably by hindering the interaction between eHSP90 and NADPH oxidase (NOX). Importantly, GV1001 suppressed HCV RNA replication in JFH-1 cells by inhibiting the binding of HSP90 to FKBP8, a member of the FK506-binding protein family. We also found that HSP90 expression was high in HCV-infected hepatocytes. Therefore, our data suggest that GV1001 may be a good therapeutic agent by controlling HCV RNA replication, as well as by preferentially targeting cells under conditions of oxidative stress.
References
Jan 31, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jinah ChoiJing-Hsiung Ou
Jun 14, 2005·Nature Medicine·Takaji WakitaT Jake Liang
Oct 7, 2006·The EMBO Journal·Toru OkamotoYoshiharu Matsuura
Jan 24, 2007·Physiological Reviews·Karen Bedard, Karl-Heinz Krause
Aug 25, 2007·Journal of Gastroenterology and Hepatology·Kazuhiko Koike
Apr 25, 2009·Expert Opinion on Investigational Drugs·Jon Amund Kyte
Jan 16, 2010·Journal of Gastroenterology and Hepatology·Sampa PalAditi Das
Mar 17, 2010·Gastroenterology·Wenyu LinRaymond T Chung
Aug 18, 2010·The Journal of Cell Biology·Mark T HowesRobert G Parton
Sep 9, 2010·Expert Review of Vaccines·V E ShawG W Middleton
Jan 5, 2011·Antioxidants & Redox Signaling·Feng ChenDavid J R Fulton
Sep 29, 2011·Biochimica Et Biophysica Acta·Jing LiJohannes Buchner
Aug 31, 2012·Oncoimmunology·Else-Marit Inderberg-SusoGustav Gaudernack
Jan 30, 2013·Viruses·Alexander V IvanovSergey N Kochetkov
Jul 6, 2013·Biomaterials·Seoung-Ae LeeBum-Joon Kim
Dec 19, 2013·PloS One·Susan ObeidJan Paeshuyse
Jan 15, 2014·Biomaterials·Bu-Kyung KimBum-Joon Kim
May 13, 2014·Transplantation Proceedings·T Y KooJ Yang
Jun 13, 2014·International Journal of Oncology·Caroline StaffMaria Liljefors
Jun 24, 2014·The Lancet Oncology·Gary MiddletonJohn Neoptolemos
Citations
Jul 2, 2016·Scientific Reports·Hong KimBum-Joon Kim
Dec 13, 2016·International Journal of Molecular Sciences·Hong KimBum-Joon Kim
Dec 7, 2016·Journal of Medical Virology·Bao Ngoc NguyenMasatoshi Hagiwara
Mar 24, 2018·International Journal of Molecular Medicine·Wei ChenMo K Kang
Jan 9, 2019·Frontiers in Pharmacology·Hu LiJian-Dong Jiang
Jun 9, 2020·Frontiers in Immunology·Yu-Min ChoiBum-Joon Kim
Sep 24, 2019·Current Aging Science·Joan Smith-Sonneborn
Apr 25, 2019·International Journal of Molecular Sciences·Eishiro Mizukoshi, Shuichi Kaneko
Dec 19, 2020·Viruses·Ines Moranguinho, Susana T Valente
Feb 3, 2021·Cancer Treatment and Research Communications·Ali Salimi-JedaAsghar Abdoli